Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, N-Methyl-D-Aspartate | 69 | 2024 | 892 | 10.350 |
Why?
|
Racemases and Epimerases | 32 | 2021 | 112 | 9.220 |
Why?
|
Serine | 27 | 2021 | 828 | 5.780 |
Why?
|
Schizophrenia | 69 | 2024 | 6913 | 5.080 |
Why?
|
Glutamic Acid | 27 | 2024 | 1167 | 3.610 |
Why?
|
Dipeptides | 21 | 2012 | 386 | 2.210 |
Why?
|
Glutamate Carboxypeptidase II | 18 | 2012 | 80 | 1.860 |
Why?
|
Glutamates | 11 | 2006 | 389 | 1.740 |
Why?
|
Neurons | 35 | 2022 | 9418 | 1.670 |
Why?
|
Astrocytes | 9 | 2019 | 1337 | 1.670 |
Why?
|
Glycine | 20 | 2019 | 662 | 1.650 |
Why?
|
Hippocampus | 23 | 2019 | 3736 | 1.610 |
Why?
|
Receptors, Glutamate | 12 | 2020 | 228 | 1.510 |
Why?
|
Dendrites | 6 | 2020 | 474 | 1.400 |
Why?
|
Synapses | 12 | 2024 | 1757 | 1.390 |
Why?
|
Antipsychotic Agents | 20 | 2017 | 3060 | 1.310 |
Why?
|
Neuronal Plasticity | 13 | 2020 | 1429 | 1.270 |
Why?
|
Prefrontal Cortex | 11 | 2021 | 2209 | 1.120 |
Why?
|
Carboxypeptidases | 8 | 2004 | 154 | 1.080 |
Why?
|
Pyramidal Cells | 8 | 2020 | 368 | 1.080 |
Why?
|
Excitatory Amino Acid Agonists | 5 | 2020 | 143 | 1.040 |
Why?
|
Antigens, Surface | 9 | 2009 | 1607 | 1.040 |
Why?
|
Mice, Knockout | 33 | 2021 | 14354 | 1.000 |
Why?
|
Kainic Acid | 9 | 2005 | 198 | 0.970 |
Why?
|
Schizophrenic Psychology | 9 | 2017 | 1646 | 0.950 |
Why?
|
Dendritic Spines | 6 | 2017 | 243 | 0.940 |
Why?
|
Synaptic Transmission | 16 | 2021 | 1168 | 0.930 |
Why?
|
Behavior, Animal | 7 | 2014 | 1867 | 0.930 |
Why?
|
Conditioning, Classical | 2 | 2017 | 365 | 0.930 |
Why?
|
Brain | 36 | 2022 | 26951 | 0.920 |
Why?
|
Prosencephalon | 4 | 2014 | 305 | 0.910 |
Why?
|
Dizocilpine Maleate | 7 | 2020 | 172 | 0.910 |
Why?
|
Animals | 121 | 2024 | 167777 | 0.880 |
Why?
|
Cocaine | 4 | 2020 | 958 | 0.880 |
Why?
|
Cognition Disorders | 11 | 2016 | 3975 | 0.850 |
Why?
|
Excitatory Amino Acid Antagonists | 11 | 2015 | 448 | 0.840 |
Why?
|
Entorhinal Cortex | 2 | 2019 | 286 | 0.820 |
Why?
|
Interneurons | 6 | 2022 | 591 | 0.820 |
Why?
|
Neurotransmitter Agents | 8 | 2010 | 663 | 0.780 |
Why?
|
D-Amino-Acid Oxidase | 2 | 2020 | 26 | 0.770 |
Why?
|
Cocaine-Related Disorders | 2 | 2015 | 461 | 0.730 |
Why?
|
Nerve Tissue Proteins | 9 | 2021 | 4406 | 0.730 |
Why?
|
Motor Activity | 7 | 2015 | 2686 | 0.720 |
Why?
|
gamma-Aminobutyric Acid | 9 | 2020 | 1132 | 0.710 |
Why?
|
Neurosciences | 3 | 2016 | 353 | 0.710 |
Why?
|
Clozapine | 8 | 2014 | 506 | 0.710 |
Why?
|
Periodicals as Topic | 8 | 2013 | 1462 | 0.700 |
Why?
|
Neuropeptides | 10 | 1998 | 943 | 0.690 |
Why?
|
Dopamine | 8 | 2024 | 1599 | 0.650 |
Why?
|
Glycine Plasma Membrane Transport Proteins | 8 | 2016 | 21 | 0.640 |
Why?
|
Cycloserine | 6 | 2005 | 118 | 0.630 |
Why?
|
Mice | 50 | 2024 | 81107 | 0.620 |
Why?
|
Haloperidol | 4 | 2014 | 388 | 0.610 |
Why?
|
Fear | 2 | 2017 | 1462 | 0.610 |
Why?
|
Allosteric Regulation | 4 | 2016 | 426 | 0.600 |
Why?
|
Self Stimulation | 1 | 2017 | 47 | 0.600 |
Why?
|
Somatosensory Cortex | 2 | 2012 | 511 | 0.600 |
Why?
|
Nucleus Accumbens | 2 | 2017 | 365 | 0.570 |
Why?
|
Gene Expression Regulation | 11 | 2021 | 11894 | 0.570 |
Why?
|
Dipeptidases | 5 | 1997 | 38 | 0.560 |
Why?
|
Cerebral Cortex | 11 | 2020 | 5759 | 0.540 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2017 | 297 | 0.530 |
Why?
|
Aspartic Acid | 6 | 2006 | 576 | 0.530 |
Why?
|
Callithrix | 1 | 2016 | 93 | 0.520 |
Why?
|
Disease Models, Animal | 19 | 2021 | 18125 | 0.510 |
Why?
|
Psychopharmacology | 2 | 2012 | 148 | 0.510 |
Why?
|
Reversal Learning | 1 | 2016 | 57 | 0.510 |
Why?
|
Phencyclidine | 5 | 2010 | 60 | 0.510 |
Why?
|
Names | 5 | 2012 | 54 | 0.510 |
Why?
|
Neurotoxins | 7 | 2010 | 240 | 0.510 |
Why?
|
Bipolar Disorder | 12 | 2018 | 5083 | 0.500 |
Why?
|
Rats | 35 | 2019 | 23681 | 0.500 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 490 | 0.500 |
Why?
|
Post-Synaptic Density | 2 | 2012 | 11 | 0.490 |
Why?
|
Amphetamines | 2 | 2013 | 143 | 0.480 |
Why?
|
Cholinesterase Inhibitors | 3 | 2008 | 238 | 0.480 |
Why?
|
Cerebellum | 9 | 2018 | 1497 | 0.480 |
Why?
|
Oxazoles | 1 | 2016 | 199 | 0.470 |
Why?
|
Galantamine | 2 | 2007 | 33 | 0.470 |
Why?
|
Amphetamine | 3 | 2012 | 224 | 0.470 |
Why?
|
Discrimination Learning | 1 | 2016 | 278 | 0.460 |
Why?
|
Psychiatry | 5 | 2013 | 1690 | 0.450 |
Why?
|
Excitatory Postsynaptic Potentials | 4 | 2013 | 368 | 0.440 |
Why?
|
Receptors, Dopamine | 4 | 2021 | 293 | 0.440 |
Why?
|
Parvalbumins | 2 | 2017 | 260 | 0.440 |
Why?
|
Extinction, Psychological | 2 | 2017 | 371 | 0.440 |
Why?
|
Nitroprusside | 1 | 2013 | 272 | 0.430 |
Why?
|
Signal Transduction | 15 | 2019 | 23341 | 0.430 |
Why?
|
Mice, Inbred C57BL | 17 | 2021 | 22006 | 0.430 |
Why?
|
Phencyclidine Abuse | 1 | 2012 | 8 | 0.430 |
Why?
|
Maze Learning | 2 | 2012 | 477 | 0.420 |
Why?
|
Cytoskeletal Proteins | 2 | 2017 | 1342 | 0.420 |
Why?
|
Serotonin Receptor Agonists | 1 | 2013 | 151 | 0.420 |
Why?
|
Superoxide Dismutase | 5 | 1998 | 593 | 0.420 |
Why?
|
Receptors, Amino Acid | 1 | 2012 | 30 | 0.410 |
Why?
|
Neuroglia | 4 | 2005 | 944 | 0.410 |
Why?
|
Alcoholism | 4 | 2013 | 1964 | 0.410 |
Why?
|
Corpus Striatum | 6 | 2020 | 1233 | 0.410 |
Why?
|
Research | 1 | 2020 | 1976 | 0.400 |
Why?
|
Anesthetics, Dissociative | 1 | 2012 | 80 | 0.400 |
Why?
|
Long-Term Potentiation | 4 | 2016 | 293 | 0.400 |
Why?
|
Amygdala | 2 | 2017 | 1351 | 0.390 |
Why?
|
Psychoses, Substance-Induced | 1 | 2012 | 99 | 0.390 |
Why?
|
Alzheimer Disease | 9 | 2019 | 8544 | 0.390 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2016 | 3758 | 0.390 |
Why?
|
Homocysteine | 2 | 2005 | 638 | 0.390 |
Why?
|
Folic Acid Deficiency | 1 | 2012 | 117 | 0.380 |
Why?
|
Psychotropic Drugs | 4 | 2019 | 883 | 0.370 |
Why?
|
Auditory Cortex | 1 | 2015 | 362 | 0.370 |
Why?
|
Receptors, Nicotinic | 2 | 2007 | 494 | 0.370 |
Why?
|
Folic Acid | 4 | 2005 | 1309 | 0.360 |
Why?
|
Brain Chemistry | 8 | 2017 | 959 | 0.360 |
Why?
|
Humans | 122 | 2024 | 758381 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2443 | 0.330 |
Why?
|
Amino Acid Transport Systems, Neutral | 3 | 2005 | 39 | 0.330 |
Why?
|
Glycine Dehydrogenase (Decarboxylating) | 2 | 2019 | 15 | 0.320 |
Why?
|
Brain Diseases | 1 | 2017 | 1541 | 0.310 |
Why?
|
Substance-Related Disorders | 3 | 2017 | 4402 | 0.310 |
Why?
|
Excitatory Amino Acids | 2 | 2005 | 17 | 0.310 |
Why?
|
Motion Perception | 1 | 2012 | 372 | 0.310 |
Why?
|
Publishing | 5 | 2012 | 833 | 0.300 |
Why?
|
Male | 71 | 2021 | 358742 | 0.300 |
Why?
|
Behavior, Addictive | 1 | 2013 | 462 | 0.300 |
Why?
|
Nootropic Agents | 2 | 2007 | 157 | 0.290 |
Why?
|
Neural Inhibition | 2 | 2010 | 589 | 0.290 |
Why?
|
Receptors, AMPA | 3 | 2020 | 322 | 0.290 |
Why?
|
Allosteric Site | 2 | 2012 | 103 | 0.290 |
Why?
|
Hallucinogens | 1 | 2010 | 194 | 0.280 |
Why?
|
Paired-Associate Learning | 1 | 2006 | 53 | 0.280 |
Why?
|
Lithium | 2 | 2017 | 596 | 0.280 |
Why?
|
Mood Disorders | 2 | 2003 | 1124 | 0.270 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2017 | 597 | 0.270 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2012 | 6013 | 0.270 |
Why?
|
Quinoxalines | 4 | 2020 | 297 | 0.260 |
Why?
|
Rats, Sprague-Dawley | 16 | 2015 | 8144 | 0.260 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2007 | 187 | 0.260 |
Why?
|
Rett Syndrome | 1 | 2007 | 164 | 0.260 |
Why?
|
Central Nervous System Stimulants | 2 | 2012 | 1176 | 0.250 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2010 | 1171 | 0.250 |
Why?
|
Amino Acids | 5 | 2019 | 1713 | 0.250 |
Why?
|
RNA, Messenger | 9 | 2015 | 12760 | 0.250 |
Why?
|
Nerve Degeneration | 5 | 1997 | 748 | 0.240 |
Why?
|
Dairying | 1 | 2024 | 12 | 0.240 |
Why?
|
Mice, Transgenic | 9 | 2014 | 9518 | 0.240 |
Why?
|
History, 20th Century | 3 | 2020 | 2772 | 0.240 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2020 | 1842 | 0.240 |
Why?
|
Pyridines | 1 | 2016 | 2860 | 0.230 |
Why?
|
Tryptophan | 1 | 2005 | 479 | 0.220 |
Why?
|
Editorial Policies | 2 | 2012 | 456 | 0.220 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2024 | 113 | 0.220 |
Why?
|
Receptor, trkB | 2 | 2015 | 125 | 0.220 |
Why?
|
Antimanic Agents | 2 | 2006 | 520 | 0.220 |
Why?
|
Intracellular Fluid | 1 | 2003 | 201 | 0.210 |
Why?
|
Calcium Channels, L-Type | 2 | 2002 | 240 | 0.210 |
Why?
|
Atrophy | 3 | 2017 | 1627 | 0.210 |
Why?
|
Cells, Cultured | 16 | 2018 | 18942 | 0.210 |
Why?
|
Heterozygote | 1 | 2009 | 2797 | 0.210 |
Why?
|
Microglia | 3 | 2020 | 1349 | 0.200 |
Why?
|
Gene Expression | 6 | 2020 | 7583 | 0.200 |
Why?
|
Oxidative Stress | 3 | 1998 | 3100 | 0.200 |
Why?
|
Autistic Disorder | 1 | 2012 | 1216 | 0.200 |
Why?
|
Huntington Disease | 3 | 1997 | 1141 | 0.200 |
Why?
|
Glutamate Decarboxylase | 3 | 2010 | 239 | 0.200 |
Why?
|
Asperger Syndrome | 1 | 2002 | 57 | 0.200 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 250 | 0.200 |
Why?
|
Glutamine | 2 | 2016 | 575 | 0.190 |
Why?
|
Patch-Clamp Techniques | 5 | 2008 | 931 | 0.190 |
Why?
|
Psychotic Disorders | 2 | 2019 | 3197 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2013 | 10747 | 0.190 |
Why?
|
Mental Recall | 2 | 2010 | 1208 | 0.190 |
Why?
|
MicroRNAs | 3 | 2017 | 3783 | 0.190 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1753 | 0.190 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2013 | 1539 | 0.190 |
Why?
|
Antidepressive Agents | 3 | 2006 | 2889 | 0.190 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2496 | 0.180 |
Why?
|
Rotarod Performance Test | 2 | 2012 | 63 | 0.180 |
Why?
|
History, 21st Century | 2 | 2020 | 1573 | 0.180 |
Why?
|
Societies, Medical | 1 | 2013 | 3891 | 0.180 |
Why?
|
Microdialysis | 2 | 2017 | 160 | 0.180 |
Why?
|
Reactive Oxygen Species | 2 | 2002 | 2129 | 0.180 |
Why?
|
Fetal Diseases | 1 | 2005 | 911 | 0.170 |
Why?
|
Glycine Agents | 1 | 2019 | 16 | 0.170 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2015 | 408 | 0.170 |
Why?
|
Rats, Transgenic | 1 | 2019 | 69 | 0.170 |
Why?
|
Cues | 2 | 2016 | 868 | 0.170 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2017 | 4562 | 0.170 |
Why?
|
Drug Therapy, Combination | 9 | 2019 | 6293 | 0.170 |
Why?
|
Anorexia Nervosa | 1 | 2008 | 1361 | 0.160 |
Why?
|
Phenotype | 2 | 2009 | 16534 | 0.160 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11070 | 0.160 |
Why?
|
Medicine in Literature | 1 | 1999 | 31 | 0.160 |
Why?
|
Cell Survival | 5 | 2002 | 5781 | 0.160 |
Why?
|
Homozygote | 1 | 2003 | 1788 | 0.160 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 1999 | 91 | 0.150 |
Why?
|
Smoking | 2 | 2013 | 9042 | 0.150 |
Why?
|
Conditioning, Operant | 3 | 2015 | 308 | 0.150 |
Why?
|
Lipid Peroxides | 2 | 1998 | 74 | 0.150 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 186 | 0.150 |
Why?
|
Complement C3a | 1 | 2018 | 66 | 0.150 |
Why?
|
Female | 41 | 2021 | 390316 | 0.150 |
Why?
|
Histamine H1 Antagonists | 1 | 1998 | 100 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1888 | 0.150 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1998 | 165 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4581 | 0.150 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1674 | 0.150 |
Why?
|
Models, Biological | 5 | 2017 | 9461 | 0.150 |
Why?
|
Receptors, Metabotropic Glutamate | 2 | 2009 | 195 | 0.150 |
Why?
|
Mutation | 3 | 2012 | 29915 | 0.150 |
Why?
|
Needs Assessment | 1 | 2003 | 1141 | 0.150 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2007 | 1693 | 0.150 |
Why?
|
Physicians, Family | 1 | 1999 | 349 | 0.150 |
Why?
|
Nerve Tissue | 1 | 1997 | 78 | 0.140 |
Why?
|
Down-Regulation | 3 | 2017 | 2905 | 0.140 |
Why?
|
Central Nervous System Diseases | 1 | 2002 | 520 | 0.140 |
Why?
|
Trans-Activators | 1 | 2007 | 2860 | 0.140 |
Why?
|
Spouses | 1 | 1999 | 279 | 0.140 |
Why?
|
Ethanol | 3 | 1998 | 1325 | 0.140 |
Why?
|
Ion Channel Gating | 1 | 1999 | 435 | 0.140 |
Why?
|
Drug Administration Schedule | 6 | 2003 | 4839 | 0.140 |
Why?
|
Receptor, EphB3 | 1 | 2016 | 11 | 0.140 |
Why?
|
Analysis of Variance | 4 | 2015 | 6233 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1651 | 0.140 |
Why?
|
GABA Antagonists | 2 | 2008 | 120 | 0.130 |
Why?
|
Nifedipine | 3 | 2002 | 221 | 0.130 |
Why?
|
Spinal Cord | 3 | 1999 | 1815 | 0.130 |
Why?
|
Occupational Diseases | 1 | 2024 | 1486 | 0.130 |
Why?
|
Blotting, Northern | 4 | 2003 | 1543 | 0.130 |
Why?
|
Sensory Gating | 2 | 2021 | 47 | 0.130 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5779 | 0.130 |
Why?
|
Biogenic Amines | 1 | 1995 | 53 | 0.130 |
Why?
|
Space Perception | 2 | 2009 | 464 | 0.130 |
Why?
|
Culture Media | 1 | 2018 | 899 | 0.130 |
Why?
|
Circadian Rhythm | 1 | 2007 | 2567 | 0.130 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7590 | 0.130 |
Why?
|
Calcium Channels | 1 | 1999 | 618 | 0.120 |
Why?
|
Ketamine | 2 | 2012 | 516 | 0.120 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2015 | 174 | 0.120 |
Why?
|
Nervous System Diseases | 2 | 1997 | 1647 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 5 | 2016 | 36285 | 0.120 |
Why?
|
Pyruvates | 1 | 2014 | 84 | 0.120 |
Why?
|
Conflict of Interest | 1 | 1999 | 548 | 0.120 |
Why?
|
Photic Stimulation | 4 | 2020 | 1967 | 0.120 |
Why?
|
Neuropsychology | 1 | 1995 | 107 | 0.120 |
Why?
|
Retinal Ganglion Cells | 2 | 2011 | 806 | 0.120 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2014 | 65 | 0.120 |
Why?
|
Silver Staining | 2 | 2012 | 62 | 0.120 |
Why?
|
Mothers | 1 | 2005 | 2189 | 0.120 |
Why?
|
Blotting, Western | 3 | 2010 | 5031 | 0.120 |
Why?
|
Acoustic Stimulation | 2 | 2009 | 1232 | 0.120 |
Why?
|
Central Nervous System | 1 | 2002 | 1333 | 0.120 |
Why?
|
Apoptosis | 5 | 1999 | 9468 | 0.120 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 529 | 0.120 |
Why?
|
Oligodendroglia | 1 | 1998 | 537 | 0.120 |
Why?
|
Butylated Hydroxytoluene | 1 | 1993 | 8 | 0.120 |
Why?
|
Cadherins | 1 | 2019 | 898 | 0.120 |
Why?
|
Mitochondria | 4 | 2020 | 3584 | 0.120 |
Why?
|
Schwann Cells | 1 | 1995 | 196 | 0.110 |
Why?
|
Nerve Net | 2 | 2021 | 2263 | 0.110 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2013 | 93 | 0.110 |
Why?
|
Receptors, Cholinergic | 2 | 2010 | 241 | 0.110 |
Why?
|
Enteroendocrine Cells | 1 | 2014 | 77 | 0.110 |
Why?
|
Peripheral Nervous System | 1 | 1995 | 151 | 0.110 |
Why?
|
Calcium Channel Blockers | 4 | 2002 | 694 | 0.110 |
Why?
|
Choline | 1 | 1995 | 513 | 0.110 |
Why?
|
Cytoplasm | 1 | 1998 | 1514 | 0.110 |
Why?
|
N-Methylaspartate | 5 | 2015 | 231 | 0.110 |
Why?
|
Chromans | 1 | 1993 | 117 | 0.110 |
Why?
|
Cognition | 4 | 2012 | 6955 | 0.110 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1998 | 623 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2018 | 1694 | 0.110 |
Why?
|
Stereoisomerism | 1 | 2014 | 613 | 0.110 |
Why?
|
Kinetics | 6 | 2005 | 6371 | 0.110 |
Why?
|
Age Determination by Skeleton | 1 | 2013 | 126 | 0.110 |
Why?
|
Social Behavior | 3 | 2021 | 1132 | 0.110 |
Why?
|
Extracellular Space | 1 | 2015 | 564 | 0.110 |
Why?
|
Influenza, Human | 1 | 2024 | 1516 | 0.110 |
Why?
|
Dog Diseases | 1 | 1993 | 141 | 0.110 |
Why?
|
L-Serine Dehydratase | 1 | 2012 | 7 | 0.110 |
Why?
|
Base Sequence | 5 | 2007 | 12436 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2872 | 0.110 |
Why?
|
Head Movements | 1 | 2013 | 152 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2000 | 1927 | 0.100 |
Why?
|
Models, Neurological | 3 | 2008 | 1757 | 0.100 |
Why?
|
Double-Blind Method | 7 | 2019 | 12262 | 0.100 |
Why?
|
Coloring Agents | 2 | 2012 | 560 | 0.100 |
Why?
|
Memory Disorders | 2 | 2010 | 1198 | 0.100 |
Why?
|
Neuromuscular Junction | 1 | 1995 | 403 | 0.100 |
Why?
|
Hyperkinesis | 1 | 2012 | 89 | 0.100 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2014 | 362 | 0.100 |
Why?
|
Taurine | 2 | 2015 | 93 | 0.100 |
Why?
|
Nerve Regeneration | 1 | 1997 | 791 | 0.100 |
Why?
|
Neurology | 1 | 2000 | 778 | 0.100 |
Why?
|
Granulocytes | 1 | 1993 | 550 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2020 | 2621 | 0.100 |
Why?
|
Michigan | 2 | 2024 | 341 | 0.090 |
Why?
|
Vision, Ocular | 2 | 2011 | 454 | 0.090 |
Why?
|
Viral Nonstructural Proteins | 1 | 2012 | 223 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 585 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4567 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1373 | 0.090 |
Why?
|
Exons | 2 | 2009 | 2387 | 0.090 |
Why?
|
Cell Fractionation | 1 | 2011 | 251 | 0.090 |
Why?
|
Intelligence Tests | 1 | 2012 | 500 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2002 | 2211 | 0.090 |
Why?
|
Brain Injuries | 3 | 2017 | 2044 | 0.090 |
Why?
|
Behavioral Symptoms | 1 | 2012 | 186 | 0.090 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 2204 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1610 | 0.090 |
Why?
|
Muscular Atrophy, Spinal | 1 | 1993 | 258 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2012 | 327 | 0.090 |
Why?
|
Dopamine Antagonists | 2 | 2003 | 288 | 0.090 |
Why?
|
Serotonin | 2 | 2013 | 1040 | 0.090 |
Why?
|
Comorbidity | 3 | 2019 | 10495 | 0.090 |
Why?
|
Placebos | 3 | 1999 | 1661 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1133 | 0.080 |
Why?
|
Nitric Oxide | 3 | 2010 | 2131 | 0.080 |
Why?
|
Cytoprotection | 1 | 2010 | 199 | 0.080 |
Why?
|
Phosphinic Acids | 1 | 2008 | 17 | 0.080 |
Why?
|
2-Amino-5-phosphonovalerate | 2 | 2007 | 58 | 0.080 |
Why?
|
Aging | 3 | 2015 | 8651 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1972 | 0.080 |
Why?
|
Rats, Long-Evans | 2 | 2007 | 378 | 0.080 |
Why?
|
Dementia | 1 | 2003 | 2650 | 0.080 |
Why?
|
Hepatitis C | 1 | 2019 | 1579 | 0.080 |
Why?
|
Chelating Agents | 2 | 2002 | 383 | 0.080 |
Why?
|
Tissue Distribution | 3 | 1998 | 2263 | 0.080 |
Why?
|
Cloning, Molecular | 3 | 1998 | 4169 | 0.080 |
Why?
|
Electron Transport | 2 | 2002 | 206 | 0.080 |
Why?
|
Chlorpyrifos | 1 | 2008 | 19 | 0.080 |
Why?
|
Cell Death | 3 | 2002 | 1667 | 0.080 |
Why?
|
Receptors, GABA | 1 | 2010 | 305 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 1996 | 1997 | 0.070 |
Why?
|
Brain Mapping | 2 | 2006 | 6570 | 0.070 |
Why?
|
Biotin | 1 | 2008 | 253 | 0.070 |
Why?
|
Benzylamines | 1 | 2008 | 247 | 0.070 |
Why?
|
Protein Subunits | 1 | 2011 | 942 | 0.070 |
Why?
|
Adult | 20 | 2020 | 219916 | 0.070 |
Why?
|
Chemokine CXCL6 | 1 | 2007 | 14 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2007 | 17617 | 0.070 |
Why?
|
Middle Aged | 17 | 2020 | 219560 | 0.070 |
Why?
|
Perforant Pathway | 1 | 2006 | 24 | 0.070 |
Why?
|
CLOCK Proteins | 1 | 2007 | 86 | 0.070 |
Why?
|
Alcohol Deterrents | 1 | 2006 | 49 | 0.070 |
Why?
|
Osteogenesis | 1 | 2013 | 1271 | 0.070 |
Why?
|
Sodium | 2 | 2004 | 1588 | 0.070 |
Why?
|
Insecticides | 1 | 2008 | 191 | 0.070 |
Why?
|
Reference Values | 3 | 1998 | 4919 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 1999 | 3242 | 0.070 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1995 | 1489 | 0.070 |
Why?
|
DNA, Complementary | 3 | 2004 | 1991 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2015 | 7843 | 0.070 |
Why?
|
Electric Stimulation | 3 | 2007 | 1732 | 0.070 |
Why?
|
Motivation | 1 | 2016 | 1996 | 0.070 |
Why?
|
5' Untranslated Regions | 1 | 2007 | 256 | 0.070 |
Why?
|
Ikaros Transcription Factor | 1 | 2007 | 231 | 0.060 |
Why?
|
Organophosphorus Compounds | 1 | 2007 | 203 | 0.060 |
Why?
|
Temporal Lobe | 3 | 2018 | 1688 | 0.060 |
Why?
|
Luciferases | 1 | 2007 | 714 | 0.060 |
Why?
|
Lidocaine | 1 | 2008 | 537 | 0.060 |
Why?
|
Neurobiology | 1 | 2006 | 137 | 0.060 |
Why?
|
Limbic System | 2 | 2001 | 419 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2022 | 12604 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2002 | 2557 | 0.060 |
Why?
|
Memory | 2 | 2009 | 2179 | 0.060 |
Why?
|
Kynurenine | 1 | 2005 | 139 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 421 | 0.060 |
Why?
|
Homocystinuria | 1 | 2005 | 64 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1664 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
Clinical Trials as Topic | 4 | 2008 | 7985 | 0.060 |
Why?
|
Chromosomes, Human | 1 | 2006 | 442 | 0.060 |
Why?
|
Free Radicals | 2 | 1996 | 238 | 0.060 |
Why?
|
Nervous System | 1 | 2008 | 543 | 0.060 |
Why?
|
Anticonvulsants | 2 | 2006 | 1881 | 0.060 |
Why?
|
Homeostasis | 2 | 2013 | 3302 | 0.060 |
Why?
|
Vocabulary | 1 | 2005 | 165 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1751 | 0.060 |
Why?
|
Immunoblotting | 2 | 1999 | 1647 | 0.060 |
Why?
|
Basal Ganglia Diseases | 1 | 2004 | 144 | 0.060 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2005 | 275 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2002 | 2673 | 0.060 |
Why?
|
Postmortem Changes | 1 | 2004 | 119 | 0.060 |
Why?
|
Time Factors | 4 | 2013 | 39873 | 0.060 |
Why?
|
Membrane Potentials | 1 | 2007 | 1094 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18357 | 0.050 |
Why?
|
Frontal Lobe | 2 | 2014 | 1419 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1527 | 0.050 |
Why?
|
Necrosis | 2 | 1999 | 1604 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2003 | 777 | 0.050 |
Why?
|
Internet | 5 | 2012 | 3082 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.050 |
Why?
|
Piperazines | 1 | 1993 | 2511 | 0.050 |
Why?
|
Play and Playthings | 1 | 2003 | 83 | 0.050 |
Why?
|
Diet | 2 | 2004 | 8003 | 0.050 |
Why?
|
Radioligand Assay | 1 | 2003 | 366 | 0.050 |
Why?
|
Quinolinic Acid | 2 | 1999 | 67 | 0.050 |
Why?
|
Serotonin Antagonists | 1 | 2003 | 144 | 0.050 |
Why?
|
Safety Management | 1 | 2008 | 760 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2005 | 582 | 0.050 |
Why?
|
Semantics | 1 | 2006 | 601 | 0.050 |
Why?
|
Second Messenger Systems | 1 | 2003 | 202 | 0.050 |
Why?
|
Indoles | 1 | 2010 | 1828 | 0.050 |
Why?
|
Adolescent Psychiatry | 1 | 2003 | 158 | 0.050 |
Why?
|
Drug Interactions | 1 | 2007 | 1414 | 0.050 |
Why?
|
Plasmids | 1 | 2007 | 2275 | 0.050 |
Why?
|
Telephone | 2 | 1995 | 625 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1433 | 0.050 |
Why?
|
Anesthetics, Local | 1 | 2008 | 1000 | 0.050 |
Why?
|
Thalamus | 2 | 2001 | 1040 | 0.050 |
Why?
|
Calcium | 3 | 2017 | 5721 | 0.050 |
Why?
|
Leisure Activities | 1 | 2003 | 306 | 0.050 |
Why?
|
Electroconvulsive Therapy | 2 | 2006 | 500 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2009 | 2105 | 0.050 |
Why?
|
Vitamin B 12 | 1 | 2004 | 523 | 0.050 |
Why?
|
Lithium Carbonate | 1 | 2002 | 179 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4336 | 0.050 |
Why?
|
Depression | 2 | 1998 | 8057 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2006 | 2381 | 0.050 |
Why?
|
HeLa Cells | 1 | 2007 | 3096 | 0.050 |
Why?
|
Child Psychiatry | 1 | 2003 | 226 | 0.050 |
Why?
|
Spider Venoms | 1 | 2000 | 43 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2017 | 22031 | 0.050 |
Why?
|
Hematinics | 1 | 2003 | 280 | 0.050 |
Why?
|
Gene Targeting | 1 | 2004 | 837 | 0.050 |
Why?
|
Culture Media, Serum-Free | 1 | 2000 | 148 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3709 | 0.040 |
Why?
|
Structure-Activity Relationship | 2 | 2012 | 3069 | 0.040 |
Why?
|
Music | 1 | 2003 | 245 | 0.040 |
Why?
|
Psychomotor Performance | 1 | 2008 | 1878 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3734 | 0.040 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2000 | 203 | 0.040 |
Why?
|
Aged | 10 | 2018 | 168217 | 0.040 |
Why?
|
Adaptation, Ocular | 1 | 2020 | 89 | 0.040 |
Why?
|
CA1 Region, Hippocampal | 1 | 2020 | 109 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2004 | 2768 | 0.040 |
Why?
|
Speech | 1 | 2005 | 552 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 2 | 1996 | 217 | 0.040 |
Why?
|
Ryanodine | 1 | 1999 | 46 | 0.040 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1999 | 100 | 0.040 |
Why?
|
Cell Line | 3 | 2019 | 15594 | 0.040 |
Why?
|
Reading | 1 | 2003 | 529 | 0.040 |
Why?
|
Risperidone | 1 | 2002 | 379 | 0.040 |
Why?
|
Thapsigargin | 1 | 1999 | 102 | 0.040 |
Why?
|
Schizophrenia, Paranoid | 1 | 1999 | 102 | 0.040 |
Why?
|
Cell Nucleus | 3 | 1996 | 2907 | 0.040 |
Why?
|
Social Adjustment | 1 | 2002 | 632 | 0.040 |
Why?
|
Literature, Modern | 1 | 1999 | 30 | 0.040 |
Why?
|
Up-Regulation | 2 | 1998 | 4114 | 0.040 |
Why?
|
Pepstatins | 1 | 1998 | 10 | 0.040 |
Why?
|
Adolescent | 6 | 2019 | 87888 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1999 | 189 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2637 | 0.040 |
Why?
|
Isocoumarins | 1 | 1998 | 21 | 0.040 |
Why?
|
Phenanthrolines | 1 | 1998 | 49 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 575 | 0.040 |
Why?
|
Sucrose | 1 | 1999 | 156 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1900 | 0.040 |
Why?
|
Antibodies | 1 | 2007 | 2420 | 0.040 |
Why?
|
Cattle | 1 | 2024 | 3846 | 0.040 |
Why?
|
Electric Conductivity | 1 | 1999 | 405 | 0.040 |
Why?
|
Environmental Pollutants | 1 | 2008 | 1268 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1999 | 213 | 0.040 |
Why?
|
Anesthetics | 1 | 2004 | 522 | 0.040 |
Why?
|
Cobalt | 1 | 1998 | 154 | 0.040 |
Why?
|
Pregnancy | 2 | 2013 | 29742 | 0.040 |
Why?
|
Ploidies | 1 | 1998 | 275 | 0.040 |
Why?
|
Electroretinography | 1 | 2020 | 517 | 0.040 |
Why?
|
Coumarins | 1 | 1998 | 118 | 0.040 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 1998 | 26 | 0.040 |
Why?
|
Telemedicine | 1 | 1995 | 3018 | 0.040 |
Why?
|
Edetic Acid | 1 | 1998 | 282 | 0.040 |
Why?
|
Prenatal Care | 1 | 2005 | 1129 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2007 | 3380 | 0.040 |
Why?
|
Precipitin Tests | 1 | 1998 | 814 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 1 | 1997 | 346 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 12945 | 0.040 |
Why?
|
Action Potentials | 1 | 2005 | 1816 | 0.040 |
Why?
|
RNA | 1 | 2007 | 2716 | 0.040 |
Why?
|
Depressive Disorder | 2 | 2003 | 3727 | 0.040 |
Why?
|
Perception | 1 | 2004 | 1196 | 0.040 |
Why?
|
Anisomycin | 1 | 1996 | 27 | 0.040 |
Why?
|
Aurintricarboxylic Acid | 1 | 1996 | 10 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 73806 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2024 | 3056 | 0.040 |
Why?
|
Hydrolysis | 1 | 1998 | 664 | 0.040 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 1995 | 370 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 1999 | 523 | 0.040 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1998 | 175 | 0.030 |
Why?
|
Central Nervous System Depressants | 1 | 1998 | 164 | 0.030 |
Why?
|
Nerve Growth Factors | 1 | 2000 | 562 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1998 | 1141 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2001 | 851 | 0.030 |
Why?
|
Encephalitis | 1 | 2020 | 438 | 0.030 |
Why?
|
Leucine | 1 | 1998 | 547 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1339 | 0.030 |
Why?
|
Photoreceptor Cells | 1 | 1997 | 236 | 0.030 |
Why?
|
Cohort Studies | 2 | 2018 | 41252 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 1998 | 11336 | 0.030 |
Why?
|
Neurodegenerative Diseases | 1 | 2005 | 1081 | 0.030 |
Why?
|
Gliosis | 1 | 2017 | 244 | 0.030 |
Why?
|
Dactinomycin | 1 | 1996 | 304 | 0.030 |
Why?
|
Cycloheximide | 1 | 1996 | 343 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2010 | 3047 | 0.030 |
Why?
|
United States | 7 | 2012 | 72140 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1977 | 208 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 1998 | 4711 | 0.030 |
Why?
|
Glutathione | 1 | 1998 | 579 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1705 | 0.030 |
Why?
|
Brain Waves | 1 | 2020 | 401 | 0.030 |
Why?
|
Psychoses, Alcoholic | 1 | 1995 | 1 | 0.030 |
Why?
|
Caudate Nucleus | 1 | 1977 | 389 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9405 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1997 | 1060 | 0.030 |
Why?
|
Young Adult | 6 | 2020 | 58808 | 0.030 |
Why?
|
Risk | 2 | 2008 | 9599 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2003 | 10146 | 0.030 |
Why?
|
Pyrrolidines | 1 | 1977 | 337 | 0.030 |
Why?
|
Choline O-Acetyltransferase | 1 | 1995 | 155 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1745 | 0.030 |
Why?
|
Phrenic Nerve | 1 | 1995 | 79 | 0.030 |
Why?
|
Organ Specificity | 1 | 1999 | 1955 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2015 | 2359 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2385 | 0.030 |
Why?
|
Intestines | 1 | 2003 | 1906 | 0.030 |
Why?
|
Zinc | 1 | 1999 | 687 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1998 | 754 | 0.030 |
Why?
|
Binding Sites | 2 | 2004 | 6036 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 1995 | 866 | 0.030 |
Why?
|
Arachidonic Acid | 1 | 1996 | 427 | 0.030 |
Why?
|
Methionine | 1 | 1996 | 569 | 0.030 |
Why?
|
Forensic Anthropology | 1 | 2013 | 8 | 0.030 |
Why?
|
Substrate Specificity | 1 | 1998 | 1792 | 0.030 |
Why?
|
Norepinephrine | 2 | 1993 | 897 | 0.030 |
Why?
|
Diencephalon | 1 | 1993 | 54 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2000 | 955 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1897 | 0.030 |
Why?
|
Molecular Probes | 1 | 1995 | 310 | 0.030 |
Why?
|
Ireland | 1 | 2013 | 171 | 0.030 |
Why?
|
Vertebrates | 1 | 1995 | 228 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1185 | 0.030 |
Why?
|
Gliotoxin | 1 | 2013 | 3 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1507 | 0.030 |
Why?
|
Ion Channels | 1 | 1998 | 1043 | 0.030 |
Why?
|
Iron | 1 | 2002 | 1786 | 0.030 |
Why?
|
CpG Islands | 1 | 2018 | 1221 | 0.030 |
Why?
|
Guinea Pigs | 1 | 1995 | 1317 | 0.030 |
Why?
|
Cell Count | 1 | 1997 | 1835 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1995 | 550 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2882 | 0.030 |
Why?
|
Gene Library | 1 | 1996 | 1059 | 0.030 |
Why?
|
Benzodiazepines | 1 | 1999 | 1130 | 0.030 |
Why?
|
Telencephalon | 1 | 1993 | 142 | 0.030 |
Why?
|
Dextroamphetamine | 1 | 1973 | 134 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2008 | 4411 | 0.030 |
Why?
|
Epiphyses | 1 | 2013 | 190 | 0.030 |
Why?
|
DNA | 2 | 1996 | 7199 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17768 | 0.030 |
Why?
|
Nitroarginine | 1 | 1992 | 66 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2004 | 15785 | 0.030 |
Why?
|
Television | 1 | 1995 | 409 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1993 | 410 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3526 | 0.030 |
Why?
|
Brain Stem | 1 | 1997 | 857 | 0.030 |
Why?
|
Isoenzymes | 1 | 1997 | 1686 | 0.020 |
Why?
|
Azo Compounds | 1 | 1992 | 117 | 0.020 |
Why?
|
Endopeptidases | 1 | 1996 | 772 | 0.020 |
Why?
|
Avoidance Learning | 1 | 1973 | 248 | 0.020 |
Why?
|
Fibula | 1 | 2013 | 265 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2000 | 2858 | 0.020 |
Why?
|
Cyclic GMP | 1 | 1992 | 395 | 0.020 |
Why?
|
Adrenal Glands | 1 | 1973 | 554 | 0.020 |
Why?
|
Forecasting | 1 | 2000 | 2920 | 0.020 |
Why?
|
Pyrroles | 1 | 1977 | 1130 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1995 | 2470 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12076 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6127 | 0.020 |
Why?
|
Psychotherapy | 1 | 1999 | 1640 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2012 | 0.020 |
Why?
|
Nitro Compounds | 1 | 2010 | 74 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 1993 | 728 | 0.020 |
Why?
|
Isomerism | 1 | 2010 | 197 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1996 | 3593 | 0.020 |
Why?
|
Genome | 1 | 2018 | 1739 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1996 | 2222 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2010 | 174 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58681 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1998 | 6068 | 0.020 |
Why?
|
Neostriatum | 2 | 2000 | 246 | 0.020 |
Why?
|
Mental Disorders | 2 | 2000 | 6803 | 0.020 |
Why?
|
Dogs | 1 | 1993 | 3838 | 0.020 |
Why?
|
Magnesium | 1 | 1992 | 809 | 0.020 |
Why?
|
Arginine | 1 | 1992 | 933 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 4745 | 0.020 |
Why?
|
Rats, Wistar | 1 | 1992 | 1844 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12951 | 0.020 |
Why?
|
Kidney | 1 | 2003 | 7016 | 0.020 |
Why?
|
Molecular Structure | 1 | 2012 | 1865 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6520 | 0.020 |
Why?
|
Brain Infarction | 1 | 2010 | 290 | 0.020 |
Why?
|
Tibia | 1 | 2013 | 1065 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2014 | 896 | 0.020 |
Why?
|
Femur | 1 | 2013 | 1302 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.020 |
Why?
|
Stem Cells | 1 | 2000 | 3521 | 0.020 |
Why?
|
Exercise | 1 | 2003 | 5788 | 0.020 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2010 | 485 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1992 | 1110 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13447 | 0.020 |
Why?
|
Treatment Outcome | 3 | 1999 | 64379 | 0.020 |
Why?
|
DNA Damage | 1 | 1996 | 2439 | 0.020 |
Why?
|
Insulin | 1 | 2000 | 6578 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 1999 | 7023 | 0.020 |
Why?
|
Light | 1 | 2011 | 1345 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3258 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6187 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1998 | 4937 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1629 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 1993 | 1894 | 0.020 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 1996 | 1463 | 0.020 |
Why?
|
Seizures | 1 | 1998 | 2919 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3754 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 1995 | 2714 | 0.010 |
Why?
|
Chlorpromazine | 1 | 2004 | 111 | 0.010 |
Why?
|
Disease Progression | 1 | 2001 | 13468 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4373 | 0.010 |
Why?
|
Verbal Behavior | 1 | 2005 | 335 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3816 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5861 | 0.010 |
Why?
|
Neural Conduction | 1 | 2005 | 441 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1992 | 4624 | 0.010 |
Why?
|
Haplorhini | 1 | 2004 | 529 | 0.010 |
Why?
|
Autoradiography | 1 | 2004 | 730 | 0.010 |
Why?
|
Models, Molecular | 1 | 2012 | 5410 | 0.010 |
Why?
|
Gene Deletion | 1 | 2010 | 2666 | 0.010 |
Why?
|
Pilot Projects | 1 | 1995 | 8554 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1995 | 4020 | 0.010 |
Why?
|
Models, Animal | 1 | 2008 | 2112 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15646 | 0.010 |
Why?
|
Electrophysiology | 1 | 2005 | 1263 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1996 | 2862 | 0.010 |
Why?
|
Epilepsy | 1 | 1997 | 3269 | 0.010 |
Why?
|
Child | 2 | 2013 | 79813 | 0.010 |
Why?
|
Sympathectomy, Chemical | 1 | 2000 | 25 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21273 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8946 | 0.010 |
Why?
|
Sympatholytics | 1 | 2000 | 82 | 0.010 |
Why?
|
Apomorphine | 1 | 2000 | 149 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2002 | 39060 | 0.010 |
Why?
|
Genes, fos | 1 | 2000 | 174 | 0.010 |
Why?
|
Drug Resistance | 1 | 2006 | 1593 | 0.010 |
Why?
|
Blood Glucose | 1 | 2014 | 6347 | 0.010 |
Why?
|
Oxidopamine | 1 | 2000 | 172 | 0.010 |
Why?
|
Stereotyped Behavior | 1 | 2000 | 135 | 0.010 |
Why?
|
Mass Screening | 1 | 1995 | 5425 | 0.010 |
Why?
|
Internship and Residency | 1 | 1999 | 5865 | 0.010 |
Why?
|
Cell Separation | 1 | 2005 | 1720 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2497 | 0.010 |
Why?
|
Bicuculline | 1 | 1998 | 96 | 0.010 |
Why?
|
Rotation | 1 | 2000 | 514 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 1988 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 2000 | 485 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 2000 | 352 | 0.010 |
Why?
|
Lysergic Acid Diethylamide | 1 | 1977 | 47 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1995 | 20052 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2000 | 1121 | 0.010 |
Why?
|
Radiochemistry | 1 | 1996 | 49 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1998 | 20500 | 0.010 |
Why?
|
Injections | 1 | 1997 | 830 | 0.010 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 1973 | 74 | 0.010 |
Why?
|
Pyrrolidinones | 1 | 1993 | 116 | 0.010 |
Why?
|
Tritium | 1 | 1973 | 707 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1973 | 2090 | 0.010 |
Why?
|
Methyltransferases | 1 | 1973 | 374 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2000 | 2731 | 0.010 |
Why?
|
Hemodynamics | 1 | 2000 | 4159 | 0.010 |
Why?
|
Phosphorylation | 1 | 2000 | 8297 | 0.010 |
Why?
|
Species Specificity | 1 | 1973 | 2417 | 0.010 |
Why?
|
Tyrosine | 1 | 1973 | 1432 | 0.010 |
Why?
|
Data Collection | 1 | 1995 | 3322 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1995 | 25953 | 0.000 |
Why?
|